Malignant Testicular Non-Seminomatous Germ Cell Tumor

general

A classification of testicular cancers that arise in specialized sex cells called germ cells. Nonseminomas include embryonal carcinoma, teratoma, choriocarcinoma, and yolk sac tumor.

Centers

Active Trials

$7.8B

Cancer Funding

Specific Cancer Types(2)

Name	Centers	Active Trials
Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor	33	—
Testicular Yolk Sac Tumor	33	—

Top Centers for Malignant Testicular Non-Seminomatous Germ Cell Tumor(33)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Active Trials	Cancer Funding	Score
1	Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive	—	$827M	—
2	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins UniversityBaltimore, MD NCI Comprehensive	—	$738M	—
3	Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive	—	$655M	—
4	UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive	—	$569M	—
5	Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive	—	$507M	—
6	Dan L Duncan Comprehensive Cancer Center at Baylor College of MedicineHouston, TX NCI Comprehensive	—	$484M	—
7	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive	—	$452M	—
8	Winship Cancer InstituteAtlanta, GA NCI Comprehensive	—	$375M	—
9	The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive	—	$370M	—
10	Comprehensive Cancer Center St. Jude Children’s Research HospitalMemphis, TN NCI Comprehensive	—	$332M	—
11	University of Colorado Cancer CenterAurora, CO NCI Comprehensive	—	$319M	—
12	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive	—	$222M	—
13	Indiana University Melvin and Bren Simon Comprehensive Cancer CenterIndianapolis, IN NCI Comprehensive	—	$216M	—
14	Sylvester Comprehensive Cancer CenterMiami, FL NCI Clinical	—	$194M	—
15	The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive	—	$186M	—
16	Cedars-Sinai CancerLos Angeles, CA	—	$179M	—
17	Cleveland Clinic Cancer CenterCleveland, OH	—	$150M	—
18	Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive	—	$123M	—
19	University of Illinois Cancer CenterChicago, IL	—	$122M	—
20	University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical	—	$116M	—
21	University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM NCI Comprehensive	—	$110M	—
22	UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR	—	$106M	—
23	Boston University Cancer CenterBoston, MA	—	$98M	—
24	Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX	—	$83M	—
25	Cancer Center at IllinoisUrbana, IL	—	$81M	—
26	Penn State Cancer InstituteHershey, PA	—	$73M	—
27	University of Cincinnati Cancer CenterCincinnati, OH	—	$71M	—
28	University of Puerto Rico Comprehensive Cancer CenterSan Juan, PR	—	$34M	—
29	Upstate Cancer CenterSyracuse, NY	—	$15M	—
30	BC CancerVancouver, BC	—	—	—
31	Tampa General Hospital Cancer InstituteTampa, FL	—	—	—
32	Princess Margaret Cancer CentreToronto, ON	—	—	—
33	Louisiana Cancer Research CenterNew Orleans, LA	—	—	—

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →